WuXi AppTec (OTCMKTS:WUXIF – Get Free Report) is expected to be releasing its results after the market closes on Monday, October 26th. Analysts expect WuXi AppTec to post earnings of $0.4375 per share and revenue of $2.39 billion for the quarter.
WuXi AppTec Stock Performance
OTCMKTS WUXIF opened at $24.98 on Friday. The company’s fifty day moving average is $26.29 and its two-hundred day moving average is $21.03. WuXi AppTec has a 52-week low of $13.60 and a 52-week high of $29.10.
About WuXi AppTec
WuXi AppTec is a China-based contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. The company provides integrated services that help customers discover, develop, test and manufacture medicines and healthcare products.
Its offerings include drug-discovery research, medicinal chemistry, biology, preclinical and clinical development, analytical and regulatory testing, and manufacturing of active pharmaceutical ingredients, drug products and advanced therapies.
Further Reading
- Five stocks we like better than WuXi AppTec
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
